O	O	0	5	Human	Human	B-NP	JJ	O	10	NMOD	O
O	O	6	7	T	T	I-NP	NN	O	10	NMOD	O
O	O	7	8	-	-	I-NP	HYPH	O	10	NMOD	O
O	O	8	12	cell	cell	I-NP	NN	O	10	NMOD	O
O	O	13	21	leukemia	leukemia	I-NP	NN	O	10	NMOD	O
O	O	22	27	virus	virus	I-NP	NN	O	10	NMOD	O
O	O	28	32	type	type	I-NP	NN	O	10	NMOD	O
O	O	33	34	I	I	I-NP	CD	O	10	NMOD	O
T1	B-Protein	35	38	Tax	Tax	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	39	49	activation	activation	I-NP	NN	O	18	SUB	O
O	O	50	52	of	of	B-PP	IN	O	10	NMOD	O
T20	B-Entity	53	55	NF	NF	B-NP	NN	B-protein	15	NMOD	B-protein
T20	I-Entity	55	56	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T20	I-Entity	56	61	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T20	I-Entity	62	63	B	B	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	63	64	/	/	O	SYM	O	17	NMOD	O
O	O	64	67	Rel	Rel	B-NP	NN	B-protein	11	PMOD	B-protein
O	O	68	76	involves	involve	B-VP	VBZ	O	0	ROOT	O
O	O	77	92	phosphorylation	phosphorylation	B-NP	NN	O	21	NMOD	O
O	O	93	96	and	and	I-NP	CC	O	21	NMOD	O
O	O	97	108	degradation	degradation	I-NP	NN	O	18	OBJ	O
O	O	109	111	of	of	B-PP	IN	O	21	NMOD	O
T2	B-Protein	112	113	I	I	B-NP	NN	B-protein	26	NMOD	B-protein
T2	I-Protein	114	119	kappa	kappa	I-NP	NN	I-protein	26	NMOD	I-protein
T2	I-Protein	120	121	B	B	I-NP	NN	I-protein	26	NMOD	I-protein
T2	I-Protein	122	127	alpha	alpha	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	128	131	and	and	O	CC	O	30	NMOD	O
T3	B-Protein	132	136	RelA	RelA	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	137	138	(	(	O	(	I-protein	30	NMOD	I-protein
T4	B-Protein	138	141	p65	p65	B-NP	NN	I-protein	34	NMOD	I-protein
O	O	141	142	)	)	O	)	I-protein	30	NMOD	I-protein
O	O	142	143	-	-	O	HYPH	I-protein	30	P	I-protein
O	O	143	151	mediated	mediate	B-NP	VBN	O	34	NMOD	O
O	O	152	161	induction	induction	I-NP	NN	O	22	PMOD	O
O	O	162	164	of	of	B-PP	IN	O	34	NMOD	O
O	O	165	168	the	the	B-NP	DT	O	40	NMOD	O
T21	B-Entity	169	170	c	c	I-NP	NN	B-DNA	40	NMOD	B-DNA
T21	I-Entity	170	171	-	-	B-NP	HYPH	I-DNA	40	NMOD	I-DNA
T21	I-Entity	171	174	rel	rel	I-NP	NN	I-DNA	40	NMOD	I-DNA
T21	I-Entity	175	179	gene	gene	I-NP	NN	I-DNA	35	PMOD	I-DNA
O	O	179	180	.	.	O	.	O	18	P	O

O	O	182	185	The	The	B-NP	DT	O	4	NMOD	O
T5	B-Protein	186	189	tax	tax	I-NP	NN	B-protein	4	NMOD	B-protein
O	O	190	194	gene	gene	I-NP	NN	I-protein	4	NMOD	I-protein
O	O	195	202	product	product	I-NP	NN	I-protein	19	SUB	I-protein
O	O	203	205	of	of	B-PP	IN	O	4	NMOD	O
O	O	206	211	human	human	B-NP	JJ	O	5	PMOD	O
O	O	212	213	T	T	I-NP	NN	O	6	NMOD	O
O	O	213	214	-	-	I-NP	HYPH	O	7	NMOD	O
O	O	214	218	cell	cell	I-NP	NN	O	12	NMOD	O
O	O	219	227	leukemia	leukemia	I-NP	NN	O	12	NMOD	O
O	O	228	233	virus	virus	I-NP	NN	O	12	NMOD	O
O	O	234	238	type	type	I-NP	NN	O	8	PMOD	O
O	O	239	240	I	I	I-NP	CD	O	12	NMOD	O
O	O	241	242	(	(	O	(	O	18	DEP	O
O	O	242	246	HTLV	HTLV	B-NP	NN	O	17	NMOD	O
O	O	246	247	-	-	B-NP	HYPH	O	17	P	O
O	O	247	248	I	I	I-NP	NN	O	18	DEP	O
O	O	248	249	)	)	O	)	O	12	NMOD	O
O	O	250	252	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	253	254	a	a	B-NP	DT	O	23	NMOD	O
O	O	255	261	potent	potent	I-NP	JJ	O	23	NMOD	O
O	O	262	277	transcriptional	transcriptional	I-NP	JJ	B-protein	23	NMOD	B-protein
O	O	278	287	activator	activator	I-NP	NN	I-protein	19	PRD	I-protein
O	O	288	292	that	that	B-NP	WDT	O	23	NMOD	O
O	O	293	297	both	both	O	CC	O	26	VMOD	O
O	O	298	308	stimulates	stimulate	B-VP	VBZ	O	24	SBAR	O
T22	B-Entity	309	314	viral	viral	B-NP	JJ	O	29	NMOD	O
T22	I-Entity	315	319	gene	gene	I-NP	NN	O	29	NMOD	O
O	O	320	330	expression	expression	I-NP	NN	O	26	OBJ	O
O	O	331	334	and	and	O	CC	O	26	VMOD	O
O	O	335	344	activates	activate	B-VP	VBZ	O	26	VMOD	O
O	O	345	347	an	an	B-NP	DT	O	33	NMOD	O
O	O	348	353	array	array	I-NP	NN	O	31	OBJ	O
O	O	354	356	of	of	B-PP	IN	O	33	NMOD	O
T23	B-Entity	357	365	cellular	cellular	B-NP	JJ	B-DNA	36	NMOD	B-DNA
T23	I-Entity	366	371	genes	gene	I-NP	NNS	I-DNA	34	PMOD	I-DNA
O	O	372	380	involved	involve	B-VP	VBN	O	36	NMOD	O
O	O	381	383	in	in	B-PP	IN	O	37	VMOD	O
O	O	384	385	T	T	B-NP	NN	B-cell_type	42	NMOD	B-cell_type
O	O	385	386	-	-	I-NP	HYPH	I-cell_type	42	NMOD	I-cell_type
O	O	386	390	cell	cell	I-NP	NN	I-cell_type	42	NMOD	I-cell_type
O	O	391	397	growth	growth	I-NP	NN	O	38	PMOD	O
O	O	397	398	.	.	O	.	O	19	P	O

T6	B-Protein	399	402	Tax	Tax	B-NP	NN	B-protein	2	SUB	B-protein
O	O	403	407	acts	act	B-VP	VBZ	O	0	ROOT	O
O	O	408	418	indirectly	indirectly	B-ADVP	RB	O	2	VMOD	O
O	O	419	421	by	by	B-PP	IN	O	2	VMOD	O
O	O	422	430	inducing	induce	B-VP	VBG	O	4	PMOD	O
O	O	431	433	or	or	I-VP	CC	O	5	VMOD	O
O	O	434	443	modifying	modify	I-VP	VBG	O	5	VMOD	O
O	O	444	447	the	the	B-NP	DT	O	9	NMOD	O
O	O	448	454	action	action	I-NP	NN	O	5	VMOD	O
O	O	455	457	of	of	B-PP	IN	O	9	NMOD	O
O	O	458	465	various	various	B-NP	JJ	O	14	NMOD	O
O	O	466	470	host	host	I-NP	NN	O	14	NMOD	O
O	O	471	484	transcription	transcription	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	485	492	factors	factor	I-NP	NNS	I-protein	10	PMOD	I-protein
O	O	492	493	,	,	O	,	O	14	P	O
O	O	494	503	including	include	B-PP	VBG	O	14	NMOD	O
O	O	504	511	members	member	B-NP	NNS	O	16	PMOD	O
O	O	512	514	of	of	B-PP	IN	O	17	NMOD	O
O	O	515	518	the	the	B-NP	DT	O	23	NMOD	O
T24	B-Entity	519	521	NF	NF	I-NP	NN	B-protein	23	NMOD	B-protein
T24	I-Entity	521	522	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T24	I-Entity	522	527	kappa	kappa	I-NP	NN	I-protein	23	NMOD	I-protein
T24	I-Entity	528	529	B	B	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	529	530	/	/	B-NP	SYM	O	26	P	O
O	O	530	533	Rel	Rel	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	534	540	family	family	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	541	543	of	of	B-PP	IN	O	26	NMOD	O
O	O	544	552	enhancer	enhancer	B-NP	NN	B-protein	31	NMOD	B-protein
O	O	552	553	-	-	O	HYPH	I-protein	28	P	I-protein
O	O	553	560	binding	bind	B-VP	VBG	I-protein	31	NMOD	I-protein
O	O	561	569	proteins	protein	B-NP	NNS	I-protein	27	PMOD	I-protein
O	O	569	570	.	.	O	.	O	2	P	O

O	O	571	573	In	In	B-PP	IN	O	16	VMOD	O
O	O	574	581	resting	rest	B-NP	VBG	B-cell_type	4	NMOD	B-cell_type
O	O	582	583	T	T	I-NP	NN	I-cell_type	4	NMOD	I-cell_type
O	O	584	589	cells	cell	I-NP	NNS	I-cell_type	1	PMOD	I-cell_type
O	O	589	590	,	,	O	,	O	16	P	O
O	O	591	595	many	many	B-NP	JJ	O	16	SUB	O
O	O	596	598	of	of	B-PP	IN	O	6	NMOD	O
O	O	599	604	these	these	B-NP	DT	O	12	NMOD	O
T25	B-Entity	605	607	NF	NF	I-NP	NN	B-protein	12	NMOD	B-protein
T25	I-Entity	607	608	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T25	I-Entity	608	613	kappa	kappa	I-NP	NN	I-protein	12	NMOD	I-protein
T25	I-Entity	614	615	B	B	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	615	616	/	/	B-VP	SYM	O	15	NMOD	O
O	O	616	619	Rel	Rel	B-NP	NN	B-protein	15	NMOD	B-protein
O	O	620	627	factors	factor	I-NP	NNS	I-protein	7	PMOD	I-protein
O	O	628	631	are	be	B-VP	VBP	O	0	ROOT	O
O	O	632	643	sequestered	sequester	I-VP	VBN	O	16	VC	O
O	O	644	646	in	in	B-PP	IN	O	17	VMOD	O
O	O	647	650	the	the	B-NP	DT	O	20	NMOD	O
O	O	651	660	cytoplasm	cytoplasm	I-NP	NN	O	18	PMOD	O
O	O	661	663	by	by	B-PP	IN	O	17	VMOD	O
O	O	664	671	various	various	B-NP	JJ	O	27	NMOD	O
T26	B-Entity	672	679	ankyrin	ankyrin	I-NP	NN	B-protein	27	NMOD	B-protein
T26	I-Entity	679	680	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T26	I-Entity	680	684	rich	rich	I-NP	JJ	I-protein	27	NMOD	I-protein
T26	I-Entity	685	695	inhibitory	inhibitory	I-NP	JJ	I-protein	27	NMOD	I-protein
T26	I-Entity	696	704	proteins	protein	I-NP	NNS	I-protein	21	PMOD	I-protein
O	O	704	705	,	,	O	,	O	27	P	O
O	O	706	715	including	include	B-PP	VBG	O	27	NMOD	O
T7	B-Protein	716	717	I	I	B-NP	NN	B-protein	33	NMOD	B-protein
T7	I-Protein	718	723	kappa	kappa	I-NP	NN	I-protein	33	NMOD	I-protein
T7	I-Protein	724	725	B	B	I-NP	NN	I-protein	33	NMOD	I-protein
T7	I-Protein	726	731	alpha	alpha	I-NP	NN	I-protein	29	PMOD	I-protein
O	O	731	732	.	.	O	.	O	16	P	O

O	O	733	737	HTLV	HTLV	B-NP	NN	O	5	NMOD	O
O	O	737	738	-	-	I-NP	HYPH	O	5	NMOD	O
O	O	738	739	I	I	I-NP	NN	O	4	NMOD	O
T8	B-Protein	740	743	Tax	Tax	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	744	754	expression	expression	I-NP	NN	O	6	SUB	O
O	O	755	760	leads	lead	B-VP	VBZ	O	36	VMOD	O
O	O	761	763	to	to	B-PP	TO	O	6	VMOD	O
O	O	764	767	the	the	B-NP	DT	O	11	NMOD	O
O	O	768	780	constitutive	constitutive	I-NP	JJ	O	11	NMOD	O
O	O	781	788	nuclear	nuclear	I-NP	JJ	O	11	NMOD	O
O	O	789	799	expression	expression	I-NP	NN	O	7	PMOD	O
O	O	800	802	of	of	B-PP	IN	O	11	NMOD	O
O	O	803	815	biologically	biologically	B-NP	RB	O	14	AMOD	O
O	O	816	822	active	active	I-NP	JJ	O	12	PMOD	O
O	O	823	825	NF	NF	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	825	826	-	-	B-VP	HYPH	I-protein	18	NMOD	I-protein
O	O	826	831	kappa	kappa	B-NP	NN	I-protein	18	NMOD	I-protein
O	O	832	833	B	B	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	834	837	and	and	O	CC	O	23	NMOD	O
T9	B-Protein	838	839	c	c	B-NP	NN	O	23	NMOD	O
T9	I-Protein	839	840	-	-	B-NP	HYPH	O	23	NMOD	O
T9	I-Protein	840	843	Rel	Rel	I-NP	NN	B-protein	23	NMOD	B-protein
T27	B-Entity	844	853	complexes	complex	I-NP	NNS	I-protein	14	NMOD	I-protein
O	O	853	854	;	;	O	:	O	36	P	O
O	O	855	862	however	however	B-ADVP	RB	O	36	VMOD	O
O	O	862	863	,	,	O	,	O	36	P	O
O	O	864	867	the	the	B-NP	DT	O	31	NMOD	O
O	O	868	879	biochemical	biochemical	I-NP	JJ	O	31	NMOD	O
O	O	880	889	mechanism	mechanism	I-NP	NN	O	31	NMOD	O
O	O	889	890	(	(	I-NP	(	O	31	NMOD	O
O	O	890	891	s	s	I-NP	NNS	O	36	SUB	O
O	O	891	892	)	)	O	)	O	31	NMOD	O
O	O	893	903	underlying	underlie	B-VP	VBG	O	31	NMOD	O
O	O	904	908	this	this	B-NP	DT	O	35	NMOD	O
O	O	909	917	response	response	I-NP	NN	O	33	OBJ	O
O	O	918	925	remains	remain	B-VP	VBZ	O	0	ROOT	O
O	O	926	932	poorly	poorly	B-ADJP	RB	O	38	VMOD	O
O	O	933	943	understood	understand	I-ADJP	VBN	O	36	VC	O
O	O	943	944	.	.	O	.	O	36	P	O

O	O	945	947	In	In	B-PP	IN	O	6	VMOD	O
O	O	948	952	this	this	B-NP	DT	O	3	NMOD	O
O	O	953	958	study	study	I-NP	NN	O	1	PMOD	O
O	O	958	959	,	,	O	,	O	6	P	O
O	O	960	962	we	we	B-NP	PRP	O	6	SUB	O
O	O	963	974	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	975	979	that	that	B-SBAR	IN	O	6	VMOD	O
T10	B-Protein	980	983	Tax	Tax	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	983	984	-	-	O	HYPH	O	8	P	O
O	O	984	994	stimulated	stimulate	B-VP	VBN	O	12	NMOD	O
O	O	995	1002	nuclear	nuclear	B-NP	JJ	O	12	NMOD	O
O	O	1003	1013	expression	expression	I-NP	NN	O	32	SUB	O
O	O	1014	1016	of	of	B-PP	IN	O	12	NMOD	O
T28	B-Entity	1017	1019	NF	NF	B-NP	NN	B-protein	17	NMOD	B-protein
T28	I-Entity	1019	1020	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T28	I-Entity	1020	1025	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
T28	I-Entity	1026	1027	B	B	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	1028	1030	in	in	B-PP	IN	O	12	NMOD	O
O	O	1031	1035	both	both	O	CC	O	18	PMOD	O
O	O	1036	1040	HTLV	HTLV	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	1040	1041	-	-	B-NP	HYPH	O	22	P	O
O	O	1041	1042	I	I	I-NP	NN	O	26	NMOD	O
O	O	1042	1043	-	-	O	HYPH	O	22	P	O
O	O	1043	1051	infected	infect	B-VP	VBN	O	22	AMOD	O
O	O	1052	1055	and	and	O	CC	O	26	NMOD	O
T11	B-Protein	1056	1059	Tax	Tax	B-NP	NN	B-protein	27	SUB	B-protein
O	O	1059	1060	-	-	B-VP	HYPH	O	19	PMOD	O
O	O	1060	1071	transfected	transfecte	B-NP	VBN	O	31	NMOD	O
O	O	1072	1077	human	human	I-NP	JJ	B-cell_type	31	NMOD	B-cell_type
O	O	1078	1079	T	T	I-NP	NN	I-cell_type	31	NMOD	I-cell_type
O	O	1080	1085	cells	cell	I-NP	NNS	I-cell_type	27	OBJ	I-cell_type
O	O	1086	1088	is	be	B-VP	VBZ	O	7	SBAR	O
O	O	1089	1099	associated	associate	I-VP	VBN	O	32	VC	O
O	O	1100	1104	with	with	B-PP	IN	O	33	VMOD	O
O	O	1105	1108	the	the	B-NP	DT	O	40	NMOD	O
O	O	1109	1124	phosphorylation	phosphorylation	I-NP	NN	O	40	NMOD	O
O	O	1125	1128	and	and	O	CC	O	40	NMOD	O
O	O	1129	1134	rapid	rapid	B-NP	JJ	O	39	AMOD	O
O	O	1135	1146	proteolytic	proteolytic	I-NP	JJ	O	40	NMOD	O
O	O	1147	1158	degradation	degradation	I-NP	NN	O	34	PMOD	O
O	O	1159	1161	of	of	B-PP	IN	O	40	NMOD	O
T12	B-Protein	1162	1163	I	I	B-NP	NN	B-protein	45	NMOD	B-protein
T12	I-Protein	1164	1169	kappa	kappa	I-NP	NN	I-protein	45	NMOD	I-protein
T12	I-Protein	1170	1171	B	B	I-NP	NN	I-protein	45	NMOD	I-protein
T12	I-Protein	1172	1177	alpha	alpha	I-NP	NN	I-protein	41	PMOD	I-protein
O	O	1177	1178	.	.	O	.	O	6	P	O

O	O	1179	1181	In	In	B-PP	IN	O	22	VMOD	O
O	O	1182	1190	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	1191	1193	to	to	B-PP	TO	O	2	NMOD	O
O	O	1194	1199	prior	prior	B-NP	JJ	O	6	AMOD	O
O	O	1200	1202	in	in	I-NP	FW	O	6	AMOD	O
O	O	1203	1208	vitro	vitro	I-NP	FW	O	7	NMOD	O
O	O	1209	1216	studies	study	I-NP	NNS	O	3	PMOD	O
O	O	1216	1217	,	,	O	,	O	22	P	O
O	O	1218	1220	at	at	B-ADVP	IN	O	12	NMOD	O
O	O	1221	1226	least	least	I-ADVP	JJS	O	9	AMOD	O
O	O	1227	1228	a	a	B-NP	DT	O	12	NMOD	O
O	O	1229	1237	fraction	fraction	I-NP	NN	O	22	SUB	O
O	O	1238	1240	of	of	B-PP	IN	O	12	NMOD	O
O	O	1241	1244	the	the	B-NP	DT	O	16	NMOD	O
O	O	1245	1259	phosphorylated	phosphorylated	I-NP	JJ	O	16	NMOD	O
O	O	1260	1264	form	form	I-NP	NN	O	13	PMOD	O
O	O	1265	1267	of	of	B-PP	IN	O	16	NMOD	O
T13	B-Protein	1268	1269	I	I	B-NP	NN	B-protein	21	NMOD	B-protein
T13	I-Protein	1270	1275	kappa	kappa	I-NP	NN	I-protein	21	NMOD	I-protein
T13	I-Protein	1276	1277	B	B	I-NP	NN	I-protein	21	NMOD	I-protein
T13	I-Protein	1278	1283	alpha	alpha	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	1284	1291	remains	remain	B-VP	VBZ	O	0	ROOT	O
O	O	1292	1302	physically	physically	B-VP	RB	O	22	VMOD	O
O	O	1303	1313	associated	associate	I-VP	VBN	O	22	VC	O
O	O	1314	1318	with	with	B-PP	IN	O	24	VMOD	O
O	O	1319	1322	the	the	B-NP	DT	O	31	NMOD	O
T29	B-Entity	1323	1325	NF	NF	I-NP	NN	B-protein	31	NMOD	B-protein
T29	I-Entity	1325	1326	-	-	B-NP	HYPH	I-protein	31	NMOD	I-protein
T29	I-Entity	1326	1331	kappa	kappa	I-NP	NN	I-protein	31	NMOD	I-protein
T29	I-Entity	1332	1333	B	B	I-NP	NN	I-protein	31	NMOD	I-protein
T29	I-Entity	1334	1341	complex	complex	I-NP	NN	I-protein	25	PMOD	I-protein
O	O	1342	1344	in	in	B-ADVP	FW	O	24	VMOD	O
O	O	1345	1349	vivo	vivo	I-ADVP	FW	O	32	AMOD	O
O	O	1350	1353	but	but	O	CC	O	22	VMOD	O
O	O	1354	1356	is	be	B-VP	VBZ	O	22	VMOD	O
O	O	1357	1364	subject	subject	B-ADJP	JJ	O	35	PRD	O
O	O	1365	1367	to	to	B-PP	TO	O	36	AMOD	O
O	O	1368	1373	rapid	rapid	B-NP	JJ	O	39	NMOD	O
O	O	1374	1385	degradation	degradation	I-NP	NN	O	37	PMOD	O
O	O	1385	1386	,	,	O	,	O	35	P	O
O	O	1387	1394	thereby	thereby	B-VP	RB	O	42	VMOD	O
O	O	1395	1404	promoting	promote	I-VP	VBG	O	35	VMOD	O
O	O	1405	1408	the	the	B-NP	DT	O	45	NMOD	O
O	O	1409	1416	nuclear	nuclear	I-NP	JJ	O	45	NMOD	O
O	O	1417	1430	translocation	translocation	I-NP	NN	O	42	OBJ	O
O	O	1431	1433	of	of	B-PP	IN	O	45	NMOD	O
O	O	1434	1437	the	the	B-NP	DT	O	48	NMOD	O
O	O	1438	1444	active	active	I-NP	JJ	O	46	PMOD	O
T30	B-Entity	1445	1447	NF	NF	I-NP	NN	B-protein	53	NMOD	B-protein
T30	I-Entity	1447	1448	-	-	B-NP	HYPH	I-protein	53	NMOD	I-protein
T30	I-Entity	1448	1453	kappa	kappa	I-NP	NN	I-protein	53	NMOD	I-protein
T30	I-Entity	1454	1455	B	B	I-NP	NN	I-protein	53	NMOD	I-protein
T30	I-Entity	1456	1463	complex	complex	I-NP	NN	I-protein	48	NMOD	I-protein
O	O	1463	1464	.	.	O	.	O	22	P	O

O	O	1465	1467	We	We	B-NP	PRP	O	3	SUB	O
O	O	1468	1475	further	further	B-ADVP	RB	O	3	VMOD	O
O	O	1476	1487	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	1488	1492	that	that	B-SBAR	IN	O	3	VMOD	O
T14	B-Protein	1493	1496	Tax	Tax	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	1497	1506	induction	induction	I-NP	NN	O	13	SUB	O
O	O	1507	1509	of	of	B-PP	IN	O	6	NMOD	O
O	O	1510	1517	nuclear	nuclear	B-NP	JJ	O	9	NMOD	O
T15	B-Protein	1518	1519	c	c	I-NP	NN	O	12	NMOD	O
T15	I-Protein	1519	1520	-	-	B-NP	HYPH	O	12	NMOD	O
T15	I-Protein	1520	1523	Rel	Rel	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	1524	1534	expression	expression	I-NP	NN	O	7	PMOD	O
O	O	1535	1537	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	1538	1547	activated	activate	I-VP	VBN	O	13	VC	O
O	O	1548	1550	by	by	B-PP	IN	O	14	VMOD	O
O	O	1551	1554	the	the	B-NP	DT	O	21	NMOD	O
T16	B-Protein	1555	1559	RelA	RelA	I-NP	NN	B-protein	21	NMOD	B-protein
O	O	1560	1561	(	(	O	(	I-protein	21	NMOD	I-protein
T17	B-Protein	1561	1564	p65	p65	B-NP	NN	I-protein	21	NMOD	I-protein
O	O	1564	1565	)	)	O	)	I-protein	21	NMOD	I-protein
O	O	1566	1573	subunit	subunit	B-NP	NN	I-protein	15	PMOD	I-protein
O	O	1574	1576	of	of	B-PP	IN	O	21	NMOD	O
T31	B-Entity	1577	1579	NF	NF	B-NP	NN	B-protein	26	NMOD	B-protein
T31	I-Entity	1579	1580	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T31	I-Entity	1580	1585	kappa	kappa	I-NP	NN	I-protein	26	NMOD	I-protein
T31	I-Entity	1586	1587	B	B	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	1587	1588	,	,	O	,	O	21	P	O
O	O	1589	1594	which	which	B-NP	WDT	O	21	NMOD	O
O	O	1595	1604	activates	activate	B-VP	VBZ	O	28	SBAR	O
O	O	1605	1618	transcription	transcription	B-NP	NN	O	29	OBJ	O
O	O	1619	1621	of	of	B-PP	IN	O	30	NMOD	O
O	O	1622	1625	the	the	B-NP	DT	O	36	NMOD	O
T18	B-Protein	1626	1627	c	c	I-NP	NN	B-DNA	36	NMOD	B-DNA
T18	I-Protein	1627	1628	-	-	B-NP	HYPH	I-DNA	36	NMOD	I-DNA
T18	I-Protein	1628	1631	rel	rel	I-NP	NN	I-DNA	36	NMOD	I-DNA
O	O	1632	1636	gene	gene	I-NP	NN	I-DNA	31	PMOD	I-DNA
O	O	1637	1644	through	through	B-PP	IN	O	29	VMOD	O
O	O	1645	1647	an	an	B-NP	DT	O	39	NMOD	O
O	O	1648	1657	intrinsic	intrinsic	I-NP	JJ	O	37	PMOD	O
T32	B-Entity	1658	1663	kappa	kappa	I-NP	NN	B-DNA	43	NMOD	B-DNA
T32	I-Entity	1664	1665	B	B	I-NP	NN	I-DNA	43	NMOD	I-DNA
T32	I-Entity	1666	1674	enhancer	enhancer	I-NP	NN	I-DNA	43	NMOD	I-DNA
T32	I-Entity	1675	1682	element	element	I-NP	NN	I-DNA	39	NMOD	I-DNA
O	O	1682	1683	.	.	O	.	O	3	P	O

O	O	1684	1686	In	In	B-PP	IN	O	13	VMOD	O
O	O	1687	1693	normal	normal	B-NP	JJ	B-cell_type	3	NMOD	B-cell_type
O	O	1694	1699	cells	cell	I-NP	NNS	I-cell_type	1	PMOD	I-cell_type
O	O	1699	1700	,	,	O	,	O	13	P	O
O	O	1701	1704	the	the	B-NP	DT	O	7	NMOD	O
O	O	1705	1715	subsequent	subsequent	I-NP	JJ	O	7	NMOD	O
O	O	1716	1728	accumulation	accumulation	I-NP	NN	O	13	SUB	O
O	O	1729	1731	of	of	B-PP	IN	O	7	NMOD	O
O	O	1732	1739	nuclear	nuclear	B-NP	JJ	O	10	NMOD	O
T19	B-Protein	1740	1741	c	c	I-NP	NN	O	12	NMOD	O
T19	I-Protein	1741	1742	-	-	B-NP	HYPH	O	12	NMOD	O
T19	I-Protein	1742	1745	Rel	Rel	I-NP	NN	B-protein	8	PMOD	B-protein
O	O	1746	1750	acts	act	B-VP	VBZ	O	0	ROOT	O
O	O	1751	1753	to	to	I-VP	TO	O	15	VMOD	O
O	O	1754	1761	inhibit	inhibit	I-VP	VB	O	13	VMOD	O
O	O	1762	1765	its	its	B-NP	PRP$	O	19	NMOD	O
O	O	1766	1769	own	own	I-NP	JJ	O	19	NMOD	O
O	O	1770	1779	continued	continued	I-NP	JJ	O	19	NMOD	O
O	O	1780	1790	production	production	I-NP	NN	O	15	OBJ	O
O	O	1790	1791	,	,	O	,	O	13	P	O
O	O	1792	1802	indicating	indicate	B-VP	VBG	O	13	VMOD	O
O	O	1803	1806	the	the	B-NP	DT	O	23	NMOD	O
O	O	1807	1815	presence	presence	I-NP	NN	O	21	OBJ	O
O	O	1816	1818	of	of	B-PP	IN	O	23	NMOD	O
O	O	1819	1821	an	an	B-NP	DT	O	27	NMOD	O
O	O	1822	1836	autoregulatory	autoregulatory	I-NP	JJ	O	27	NMOD	O
O	O	1837	1841	loop	loop	I-NP	NN	O	24	PMOD	O
O	O	1841	1842	.	.	O	.	O	13	P	O

O	O	1843	1844	(	(	O	(	O	7	DEP	O
O	O	1844	1852	ABSTRACT	ABSTRACT	B-NP	NN	O	7	DEP	O
O	O	1853	1862	TRUNCATED	TRUNCATED	B-VP	VBN	O	2	NMOD	O
O	O	1863	1865	AT	AT	B-PP	IN	O	3	VMOD	O
O	O	1866	1869	250	250	B-NP	CD	O	6	NMOD	O
O	O	1870	1875	WORDS	WORDS	I-NP	NNS	O	4	PMOD	O
O	O	1875	1876	)	)	O	)	O	0	ROOT	O
